Candriam SCA’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,000
| Closed | -$399K | – | 890 |
|
|
2022
Q3 | $399K | Sell |
14,000
-10,000
| -42% | -$285K | ﹤0.01% | 840 |
|
|
2022
Q2 | $1.09M | Buy |
24,000
+18,818
| +363% | +$852K | 0.01% | 613 |
|
|
2022
Q1 | $394K | Buy |
5,182
+848
| +20% | +$64.5K | ﹤0.01% | 754 |
|
|
2021
Q4 | $646K | Hold |
4,334
| – | – | ﹤0.01% | 727 |
|
|
2021
Q3 | $631K | Buy |
4,334
+658
| +18% | +$95.8K | ﹤0.01% | 766 |
|
|
2021
Q2 | $720K | Buy |
+3,676
| New | +$720K | ﹤0.01% | 769 |
|